Skip to content
Head to head

McKesson vs Cencora

Side-by-side on the measures that matter, with a plain-English read. Full detail: MCK · COR

Updated 8 minutes ago

1-year performance, rebased to 100

MCK +25.5%COR -6.5%
McKesson edges it on the scoreable measures. McKesson has the highest Quant Rating (72); McKesson has done best over the past year (+26%); McKesson earns the most per share.
MCKCOR
Snapshot
Sector--Medical Distribution
Last price1,069.43339.09
Change today+0.68%-0.63%
1-year return+26.4%-5.8%
Market cap$123.47B$64.71B
52-week range722.11 – 1,121.50243.32 – 374.62
Valuation
P/E (TTM)27.4818.89
P/E percentile, own 5-yr range73rd28th
P/B-31.2317.58
Dividend yield0.32%0.71%
Profitability & growth
EPS (TTM)38.5517.95
Net profit (TTM)$4.45B$3.43B
Revenue (TTM)$418.79B$337.40B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+7.6%+5.5%
Gross margin3.7%4.1%
Operating margin1.7%1.4%
Net margin1.1%1.0%
Free cash flow (TTM)$6.87B$3.88B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership89.2%101.4%
Insider activity (12mo)21 buy / 27 sell31 buy / 17 sell
Short interest (% of float)1.7%1.7%
Analyst consensus90% buy / 10% hold (10)80% buy / 20% hold (10)
Analyst price target$1,211 (+13%)$386 (+14%)
StockVane view
StockVane Quant RatingC (72)D (33)
Company
Employees43,00051,000
Founded18331947

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.